Hospital Universitario Mutua Terrassa
- Address
- Plaza del Dr. Robert 5, 08221 Terrassa, Spain
Hospital Universitario Mutua Terrassa - Cardiovascular Research Center
Hospital Universitario Mutua Terrassa is a specialized research institution focused on cardiovascular disorders, with particular expertise in cardiac arrhythmias and thrombotic complications. The center conducts advanced clinical investigations into stroke prevention strategies and anticoagulation therapies for complex patient populations.
- Atrial fibrillation associated with acute stress conditions and surgical interventions
- Novel oral anticoagulation strategies for stroke prevention
- Thromboembolism prevention in high-risk cardiovascular patients
The research team demonstrates significant commitment to evaluating non-vitamin K oral anticoagulants (NOACs) in challenging clinical scenarios, particularly in patients experiencing stress-induced atrial fibrillation following noncardiac surgery or acute medical illness. Their investigations encompass comprehensive cardiovascular endpoints including stroke, systemic embolism, myocardial infarction, and peripheral arterial thrombosis, reflecting a holistic approach to patient safety and vascular health outcomes.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 9 therapeutic areas and 15 of 75 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Top 40 of 72 compounds, ranked by number of trials.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 9 by active trials.
- 1Regeneron Pharmaceuticals Inc.3active
lock +8 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Regeneron Pharmaceuticals Inc.4trials
lock +4 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 567 other sites in Spain
Therapeutic Area Benchmark — Spain
Select a therapeutic area to compare against other sites in Spain.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Spain
Market Share
Country: Spain
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Hospital Universitario Mutua Terrassa
lock Showing 1 of 25 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Multicenter, Randomized, Double-Blind, Comparative, Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous Imipenem/Cilastatin-XNW4107 in Comparison with Imipenem/Cilastatin/Relebactam in Adults with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia | Evopoint Biosciences USA Inc. | Phase III | Not Recruiting | Apr 2024 | Jul 2024 |
IMP list
lock Showing 1 of 75 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexamethasone | 7 | Unknown | 2021-09-28 | 2024-11-05 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.